← Back to Blog

Medicaid and Gender-Affirming Care: What Families Can Do Now

Notebook and calendar on a planning table with pink, blue, and white accents, representing medicaid and gender-affirming care planning

For families navigating Medicaid and gender-affirming care, a federal funding change can raise immediate questions: Will a prescription remain covered? What happens to an upcoming appointment? Who can help explain the options?

A federal rule restricting payment for specified gender-affirming treatment through Medicaid and the Children’s Health Insurance Program (CHIP) is scheduled to take effect October 13, 2026. Families who rely on these programs should contact their treating clinic and coverage provider promptly. The official final rule sets out its requirements.

You deserve clear information and time to ask questions. Start with one manageable step: request written confirmation of how the change may affect current prescriptions and upcoming care.

What changes for Medicaid and gender-affirming care?

The rule restricts program payment and federal funding for specified treatment for Medicaid beneficiaries under 18 and beneficiaries of separate CHIP programs under 19.

Its reach has limits. It does not prohibit every form of gender-affirming care or every source of insurance coverage. States may use state-only funds outside federally matched Medicaid or CHIP, and the rule allows other non-federal funding. However, those alternatives depend on what a state or provider actually offers. See the final rule’s scope and funding provisions.

For your family, the practical question is specific: How will your program pay for the care your young person currently receives?

Ask for specific answers about Medicaid and gender-affirming care coverage

Contact both the treating clinic and the insurer or state program. Each can answer a different part of the question: the clinic can discuss treatment planning, while the coverage provider can explain benefits and payment decisions.

Use these questions to guide the conversation:

  • Will current prescriptions and treatment remain covered after October 13?
  • Does coverage differ for medication, appointments, laboratory work, or other services?
  • Should we keep an upcoming appointment while you clarify coverage?
  • Will we need a new authorization or written coverage decision?
  • Are state-funded options or financial assistance available for this treatment?
  • If you deny or reduce coverage, how do we request review or appeal?
  • Who will follow up if the clinic, pharmacy, and coverage provider give different answers?

Ask for written responses, the name of a follow-up contact, and any deadlines. If the answers conflict, ask the clinic and coverage provider to clarify the difference.

You do not need to resolve every question in one call. Begin with the next prescription or appointment, then work outward.

Plan continuity of care with your clinician

Ask the treating clinician what continuity planning makes sense for your young person. Let that conversation guide any medication decisions.

CMS describes a provision allowing federal funding for certain existing hormone therapy for up to six months from the rule’s effective date as a tapering period. This provision does not guarantee six months of unchanged treatment for everyone. CMS also states that the rule does not affect mental health coverage. Read the CMS announcement.

Ask whether the transition provision applies to your situation, which prescriptions it covers, and what written confirmation the program can provide.

Do not stop, taper, substitute, or change prescribed medication on your own because of a policy announcement. Bring questions about treatment changes to your prescribing clinician.

Court challenges remain unresolved regarding Medicaid and gender-affirming care

Families and states have challenged the rule, but a pending lawsuit does not automatically change its effective date.

On October 5, a New Hampshire federal court denied a request for a temporary restraining order in Goe v. HHS. The court directed the defendants to respond to the separate preliminary injunction request. That order did not decide the lawsuit’s merits. See the October 5 court order.

Georgetown’s litigation summaries, updated October 7 for the families’ case and October 9 for the states’ case, list ongoing briefing.

For this October 11 review, we could not verify a later nationwide order blocking the rule. Before relying on a reported court development, ask your coverage provider or qualified legal support how it applies to your circumstances.

Keep useful records and protect privacy

A small, organized set of records can make follow-up easier. Gather:

  • Current prescriptions and clinician contact information.
  • Treatment summaries and authorization records.
  • Coverage notices, written denials, and deadlines.
  • Upcoming appointment dates.
  • Dated notes from calls, including the next step each person gave you.

Store sensitive records securely and use appropriate channels when sharing them. Include the young person in conversations about support and privacy, consistent with applicable requirements. Ask what they want help with and who they feel comfortable involving. For more information on how to keep your or your loved ones’ data safe, see our previous post about data security.

If someone offers support, a specific task may help: taking notes during a call, organizing questions, or helping track responses—with your permission.

Make room for thoughtful decisions

Coverage uncertainty can become part of a larger conversation about safety or relocation. If your family is considering a move, investigate provider availability, enrollment requirements, costs, and continuity of care before making commitments. A destination’s reputation cannot confirm access to a particular treatment.

We’re also covering this policy in Signal Fires. Subscribe on Buttondown to receive the upcoming brief and future updates by email.

For now, focus on the next concrete step: contact your clinic and coverage provider, request a written answer, and identify who will help you follow up. Your family’s questions deserve attention, and your young person’s dignity belongs at the center of the conversation.

This article provides general information, not medical or legal advice. Consult your treating clinician and qualified legal support about your circumstances.

← Back to Blog